Хайлтын үр дүнгүүд - Laurent Demizieux

  • 6-н 1 - 6 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice

    CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice -н Tony Jourdan, Louiza Djaouti, Laurent Demizieux, Joseph Gresti, Bruno Vergès, Pascal Degrace

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Hepatic Steatosis Is Not Due to Impaired Fatty Acid Oxidation Capacities in C57BL/6J Mice Fed the Conjugated trans-10,cis-12-Isomer of Linoleic Acid

    Hepatic Steatosis Is Not Due to Impaired Fatty Acid Oxidation Capacities in C57BL/6J Mice Fed the Conjugated trans-10,cis-12-Isomer of Linoleic Acid -н Pascal Degrace, Laurent Demizieux, Joseph Gresti, P. Clouet, Jean‐Michel Chardigny, J.-L. Sébédio

    Хэвлэсэн 2004
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Liraglutide Increases the Catabolism of Apolipoprotein B100–Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression

    Liraglutide Increases the Catabolism of Apolipoprotein B100–Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expre... -н Bruno Vergès, Laurence Duvillard, Jean-Paul Paı̈s de Barros, Benjamin Bouillet, S. Baillot-Rudoni, Alexia Rouland, Jean‐Michel Petit, Pascal Degrace, Laurent Demizieux

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus

    Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus -н Bruno Vergès, Laurence Duvillard, Jean-Paul Paı̈s de Barros, Benjamin Bouillet, S. Baillot-Rudoni, Alexia Rouland, Anne-Laure Sberna, Jean‐Michel Petit, Pascal Degrace, Laurent Demizieux

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS

    Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS -н Damien Denimal, Serge Monier, Marie‐Claude Brindisi, Jean‐Michel Petit, Benjamin Bouillet, Amandine Nguyen, Laurent Demizieux, Isabelle Simoneau, Jean-Paul Paı̈s de Barros, Bruno Vergès, Laurence Duvillard

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes

    Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes -н Damien Denimal, Victoria Bergas, Jean-Paul Pais-de-Barros, Isabelle Simoneau, Laurent Demizieux, Patricia Passilly‐Degrace, Benjamin Bouillet, Jean‐Michel Petit, Alexia Rouland, Amandine Bataille, Laurence Duvillard, Bruno Vergès

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: